Dana-Farber/Boston Children’s Hojun Li named a 2020 Scholar Award Recipient by the American Society of Hematology

December 19, 2019

Hojun Li, MD, PhD, of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, was today named one of 39 recipients of the 2020 Scholar Awards from the American Society of Hematology (ASH). One of ASH’s most prestigious research award programs, the ASH Scholar Awards financially support fellows to junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.

“I’m incredibly honored to be recognized as an ASH Scholar alongside the many other outstanding researchers that are part of this year’s awardees,” said Li.

Each Scholar Award provides $100,000 for the Fellow level over a two- to three-year period. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society.

“For many scientists, attaining early funding for their research is a turning point, not only providing financial support but also showing that ASH believes in their potential to make impactful discoveries,” said 2020 ASH President Stephanie Lee, MD, MPH, of Fred Hutchinson Cancer Research Center. “For more than 30 years now, ASH has been supporting fellows and early career faculty with Scholar Awards. Recipients of these prestigious awards have gone on to distinguished careers, receiving more than $1 billion from various funding institutions and becoming leaders in our field. Congratulations to all the awardees.”

About the American Society of Hematology (ASH)

The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online, as well as the newly launched, online, peer-reviewed open-access journal, Blood Advances (www.bloodadvances.org).